Kamagra Oral Jelly

Description

Kamagra Oral Jelly: Sildenafil Formulation and Patient Information

Kamagra Oral Jelly is a sachet-based oral formulation listed as containing sildenafil citrate 100 mg. Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor used in clinically assessed adults with erectile dysfunction (ED). It supports blood flow during sexual stimulation but does not increase libido or treat every cause of erectile difficulties.

Product Facts

How Sildenafil Works

Sexual stimulation activates nitric-oxide signalling in penile tissue and increases cyclic guanosine monophosphate (cGMP). Sildenafil reduces cGMP breakdown by inhibiting PDE5, helping smooth muscle relax and allowing increased blood flow. Without sexual stimulation, the medicine does not automatically produce an erection.

ED can be associated with cardiovascular disease, diabetes, medication effects, mental health or hormonal concerns. Persistent symptoms warrant a medical assessment rather than simply choosing a higher dose or a different format. See our guide to erectile dysfunction medicines.

Oral Jelly Compared With Sildenafil Tablets

The main difference is the presentation: a pre-packed jelly sachet rather than a swallowed tablet. This may affect personal preference, excipients and administration instructions. It does not demonstrate that the jelly works faster, more reliably or more safely than authorised sildenafil tablets. Product-specific evidence would be required for those claims.

Dosage, food effects and timing must be based on the exact product’s verified instructions and the clinician’s prescription. The European-authorised sildenafil tablet information lists a maximum recommended 100 mg dose and no more than once daily, but this must not be interpreted as approval of this particular jelly formulation.

Who Needs Extra Caution?

• Nitrates and nitric-oxide donors: combining these with sildenafil can dangerously lower blood pressure; this includes recreational nitrite products known as ‘poppers’.
• Riociguat: a contraindicated interaction due to hypotension risk.
• Heart or blood-pressure conditions: a clinician should evaluate whether sexual activity and PDE5 inhibitors are appropriate.
• Alpha-blockers and some antihypertensives: may increase dizziness and low blood pressure.
• Strong enzyme inhibitors and other ED medicines: may increase sildenafil exposure or duplicate treatment.
• Visual disorders, severe liver or kidney disease, or a history of prolonged erections: require individual assessment.

Possible Side Effects and Warning Signs

Potential sildenafil-related side effects include headache, flushing, indigestion, dizziness, blocked nose and temporary visual changes. Rare but serious symptoms require urgent assessment, including chest pain, severe faintness, sudden vision or hearing loss, or an erection lasting more than four hours. Tell emergency clinicians if sildenafil has recently been taken.

Manufacturer, Packaging and Authenticity

The product is listed as an Ajanta Pharma brand. The actual manufacturer, active ingredient strength, excipients, batch number, expiry date and applicable approvals should be verified from the supplied original packaging and traceable manufacturer documentation. A company manufacturing jelly products does not, by itself, establish the regulatory status or quality of an individual sachet.

Check that the packaging is intact and the printed lot information can be traced. Avoid using damaged or unlabelled medicine. Store according to its original label, away from children’s reach.

Frequently Asked Questions

Medical References

• European Medicines Agency: Viagra (sildenafil) product information
• MedlinePlus: Sildenafil drug information
• Ajanta Pharma: manufacturing facilities

Educational information only. It does not establish equivalence, authorisation, authenticity or suitability of these exact products in any destination country. No named clinician has independently signed off this page.